Bong-Jo Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bong-Jo Kim has a total of 243 co-authors. Here are the top co-authors by number of shared publications:
- Young Jin Kim
Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju-si, Republic of Korea
16 shared publications Jun Ho Yun
Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju-si, 28159, Republic of Korea
6 shared publications- Hye-Mi Jang
Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju, Korea
5 shared publications Dong Mun Shin
Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju, Republic of Korea
4 shared publicationsMi Yeong Hwang
Division of Genome Research, Center for Genome Science, National Institute of Health, Osong Health Technology Administration Complex
4 shared publications- Mi Yeong Hwang
Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju-si, Republic of Korea
4 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 58 (9) , 3061-3073
Immune pathway activation in gastric cancers with LINE-1 retrotransposon overexpression and homologous recombination deficiency
There are only a few whole genome sequencing studies of human gastric cancer (GC) conducted so far. We performed comprehensive whole genome, bulk RNA, and methylation sequencing analyses of 100 samples of GC and adjacent normal tissue. In a smaller non-EBV/non-MSI subset ( n = 23), we also performed proteomic profiling by mass spectrometry. We validated the proteomic findings in an independent dataset. Using this unprecedented dataset of human GC samples, we examined the extent of chromothripsis, homologous recombination deficiency, and retrotransposition, and correlated these events with patient outcomes. We found that chromothripsis occurred in 22% of GCs and correlated with poor prognosis. Multichromosomal chromothripsis was associated with a particularly high risk of death. Based on copy number (CN) signature analysis, we identified a distinct non-CN9 subgroup with significantly worse outcomes. Homologous recombination deficiency was present in 4% of GCs and was associated with overexpression of immune signaling pathways. Somatic retrotransposition events were most strongly associated with global hypomethylation. We also identified BYSL as a putative oncogenic driver within the 6p21 locus whose amplification is associated with poor prognosis. Collectively, our findings provide novel insights into the dysregulation of DNA stability and repair and their clinical relevance in human GCs.
- 7 September 2026
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 58 (9) , 3061-3073
Open AccessImmune pathway activation in gastric cancers with LINE-1 retrotransposon overexpression and homologous recombination deficiency
There are only a few whole genome sequencing studies of human gastric cancer (GC) conducted so far. We performed comprehensive whole genome, bulk RNA, and methylation sequencing analyses of 100 samples of GC and adjacent normal tissue. In a smaller non-EBV/non-MSI subset ( n = 23), we also performed proteomic profiling by mass spectrometry. We validated the proteomic findings in an independent dataset. Using this unprecedented dataset of human GC samples, we examined the extent of chromothripsis, homologous recombination deficiency, and retrotransposition, and correlated these events with patient outcomes. We found that chromothripsis occurred in 22% of GCs and correlated with poor prognosis. Multichromosomal chromothripsis was associated with a particularly high risk of death. Based on copy number (CN) signature analysis, we identified a distinct non-CN9 subgroup with significantly worse outcomes. Homologous recombination deficiency was present in 4% of GCs and was associated with overexpression of immune signaling pathways. Somatic retrotransposition events were most strongly associated with global hypomethylation. We also identified BYSL as a putative oncogenic driver within the 6p21 locus whose amplification is associated with poor prognosis. Collectively, our findings provide novel insights into the dysregulation of DNA stability and repair and their clinical relevance in human GCs.
- Open Access
Long-read sequencing reveals novel mitochondrial genome variants undetected by short-read sequencing in Korean population
While long-read sequencing technologies (e.g., PacBio Revio, ONT) have revolutionized high-quality genome assembly for the human pangenome, mitochondrial genome (mtDNA) analysis still largely relies on short-read and Sanger sequencing. However, short-read sequencing often lacks the resolution required to resolve complex variations due to the unique features of mtDNA, such as high mutation rates and repetitive homopolymeric regions, which frequently lead to alignment artifacts and mapping ambiguities. To address this, we evaluated whether applying long-read sequencing to mtDNA improves analytical quality in empirical data. Through comprehensive bioinformatics analyses, we compared the performance of long-read sequencing against short-read sequencing and microarrays. Our results revealed that long-read sequencing detected the highest number of variants (n = 533), significantly outperforming both short-read sequencing (n = 525) and microarrays (n = 49). Notably, both sequencing methods provided significantly higher resolution in haplogroup assignment compared to microarrays in terms of phylogenetic depth (p < 0.05). Long-read sequencing demonstrated superior detection power, particularly for InDels. We identified two novel non-synonymous variants, including a unique InDel detected exclusively by long-read sequencing. Protein modeling and stability analysis validated that this InDel causes structural instability (RMSD > 2.0 Å, 𝛥𝛥G = -45.21 kcal/mol). Furthermore, we confirmed that this novel InDel is shared among haplogroup A samples in both the 1000 Genomes Project ONT dataset and the Korean population, highlighting the practical implications of long-read sequencing for molecular biology and population genetics.
Open AccessLong-read sequencing reveals novel mitochondrial genome variants undetected by short-read sequencing in Korean population
While long-read sequencing technologies (e.g., PacBio Revio, ONT) have revolutionized high-quality genome assembly for the human pangenome, mitochondrial genome (mtDNA) analysis still largely relies on short-read and Sanger sequencing. However, short-read sequencing often lacks the resolution required to resolve complex variations due to the unique features of mtDNA, such as high mutation rates and repetitive homopolymeric regions, which frequently lead to alignment artifacts and mapping ambiguities. To address this, we evaluated whether applying long-read sequencing to mtDNA improves analytical quality in empirical data. Through comprehensive bioinformatics analyses, we compared the performance of long-read sequencing against short-read sequencing and microarrays. Our results revealed that long-read sequencing detected the highest number of variants (n = 533), significantly outperforming both short-read sequencing (n = 525) and microarrays (n = 49). Notably, both sequencing methods provided significantly higher resolution in haplogroup assignment compared to microarrays in terms of phylogenetic depth (p < 0.05). Long-read sequencing demonstrated superior detection power, particularly for InDels. We identified two novel non-synonymous variants, including a unique InDel detected exclusively by long-read sequencing. Protein modeling and stability analysis validated that this InDel causes structural instability (RMSD > 2.0 Å, 𝛥𝛥G = -45.21 kcal/mol). Furthermore, we confirmed that this novel InDel is shared among haplogroup A samples in both the 1000 Genomes Project ONT dataset and the Korean population, highlighting the practical implications of long-read sequencing for molecular biology and population genetics.
- Open Access
- 17 July 2026
- Published by Elsevier in Molecular Metabolism
- Vol. 111, 102423
SAMM50 rs3761472 causes mitochondrial dysfunction and progression of metabolic dysfunction-associated steatotic liver disease
- 17 July 2026
- Published by Elsevier in Molecular Metabolism
- Vol. 111, 102423
Open AccessSAMM50 rs3761472 causes mitochondrial dysfunction and progression of metabolic dysfunction-associated steatotic liver disease
- Open Access
- 23 June 2026
- Published by Springer Nature in Research Square
A draft Korean pangenome graph from 264 assemblies reveals intrapopulation structural variation and improves ancestry-matched variant analysis
Human pangenome studies have improved representation across populations, but intrapopulation variation in homogeneous populations remains undercharacterized. Here we present a draft Korean pangenome from 264 Korean assemblies, including 8 near-T2T-level assemblies from 4 deeply sequenced individuals, as a pilot for the Korean Pangenome Project to generate 1,000 T2T-level genomes. We identified 20,194,050 SNVs, 5,406,444 small indels, 172,368 structural variants, and 1,521,240 assembly-based variants absent from major public resources. Segmental-duplication analysis defined 6,282 loci spanning 249.0 Mb and revealed Korean-enriched copy-number patterns at ARHGEF5 , AMY1/AMY2A , and C4A/C4B . The Korean pangenome graph contained 25,785,548 graph-derived variants, with 399.6 Mb of Korean private-to-low-shared sequence in the merged graph. In benchmarking, the KPP graph markedly improved SV and InDel detection over HPRC and CPC, especially in medically relevant genes and immune loci including KIR and MHC. These results establish KPP as a foundation for population-specific graph genomics in East Asia.
- 23 June 2026
- Published by Springer Nature in Research Square
Open AccessA draft Korean pangenome graph from 264 assemblies reveals intrapopulation structural variation and improves ancestry-matched variant analysis
Human pangenome studies have improved representation across populations, but intrapopulation variation in homogeneous populations remains undercharacterized. Here we present a draft Korean pangenome from 264 Korean assemblies, including 8 near-T2T-level assemblies from 4 deeply sequenced individuals, as a pilot for the Korean Pangenome Project to generate 1,000 T2T-level genomes. We identified 20,194,050 SNVs, 5,406,444 small indels, 172,368 structural variants, and 1,521,240 assembly-based variants absent from major public resources. Segmental-duplication analysis defined 6,282 loci spanning 249.0 Mb and revealed Korean-enriched copy-number patterns at ARHGEF5 , AMY1/AMY2A , and C4A/C4B . The Korean pangenome graph contained 25,785,548 graph-derived variants, with 399.6 Mb of Korean private-to-low-shared sequence in the merged graph. In benchmarking, the KPP graph markedly improved SV and InDel detection over HPRC and CPC, especially in medically relevant genes and immune loci including KIR and MHC. These results establish KPP as a foundation for population-specific graph genomics in East Asia.
- 17 June 2026
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
Genetic Landscape of Kidney Failure in a Korean Transplant Cohort
Background: Kidney failure represents the final, irreversible stage of chronic kidney disease (CKD), yet its genetic architecture remains incompletely defined compared to CKD. While prior studies largely focused on kidney function traits, the genetic determinants of kidney failure itself and its etiologic subtypes are poorly understood. Therefore, this study aimed to identify genetic loci associated with kidney failure and its subtypes and to evaluate the predictive performance of multiple polygenic risk scores (PRSs) for stratifying kidney failure risk. Methods: We performed a large-scale genome-wide association study (GWAS) using a dataset of 2,355 kidney failure patients across three subtypes defined by primary disease, along with 152,131 controls. PRSs for type 2 diabetes, hypertension, estimated glomerular filtration rate (eGFR), and CKD were calculated, and a multi-PRS model was derived. Results: The GWAS identified multiple kidney failure-associated loci, including HLA-DRB1 for all kidney failure and glomerulonephritis as the primary disease, and COL24A1 for hypertensive kidney failure at genome-wide significance (P-8 ), implicating distinct immune and hypertension-related pathways in kidney failure pathogenesis. PRS analysis revealed that genetically distinct components of type 2 diabetes, hypertension, CKD, and eGFR were significantly linked to kidney failure risk across subtypes (OR=1.1–2.5). A combined multi-PRS model demonstrated superior predictive performance (OR=1.5–2.5). Comparison with CKD cohorts, predominantly influenced by eGFR-related genetics, uncovered unique kidney failure-specific genetic signatures, highlighting kidney failure as a genetically heterogeneous and multifactorial disease beyond CKD. Conclusions: This study identified subtype-specific genetic loci and demonstrated that multi-PRS models improve kidney failure risk prediction beyond basic available clinical factors.
- 17 June 2026
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
Genetic Landscape of Kidney Failure in a Korean Transplant Cohort
Background: Kidney failure represents the final, irreversible stage of chronic kidney disease (CKD), yet its genetic architecture remains incompletely defined compared to CKD. While prior studies largely focused on kidney function traits, the genetic determinants of kidney failure itself and its etiologic subtypes are poorly understood. Therefore, this study aimed to identify genetic loci associated with kidney failure and its subtypes and to evaluate the predictive performance of multiple polygenic risk scores (PRSs) for stratifying kidney failure risk. Methods: We performed a large-scale genome-wide association study (GWAS) using a dataset of 2,355 kidney failure patients across three subtypes defined by primary disease, along with 152,131 controls. PRSs for type 2 diabetes, hypertension, estimated glomerular filtration rate (eGFR), and CKD were calculated, and a multi-PRS model was derived. Results: The GWAS identified multiple kidney failure-associated loci, including HLA-DRB1 for all kidney failure and glomerulonephritis as the primary disease, and COL24A1 for hypertensive kidney failure at genome-wide significance (P-8 ), implicating distinct immune and hypertension-related pathways in kidney failure pathogenesis. PRS analysis revealed that genetically distinct components of type 2 diabetes, hypertension, CKD, and eGFR were significantly linked to kidney failure risk across subtypes (OR=1.1–2.5). A combined multi-PRS model demonstrated superior predictive performance (OR=1.5–2.5). Comparison with CKD cohorts, predominantly influenced by eGFR-related genetics, uncovered unique kidney failure-specific genetic signatures, highlighting kidney failure as a genetically heterogeneous and multifactorial disease beyond CKD. Conclusions: This study identified subtype-specific genetic loci and demonstrated that multi-PRS models improve kidney failure risk prediction beyond basic available clinical factors.
- Open Access
- 1 June 2026
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 2 (2) , e000087
Middle-Aged Carotid Plaque and Cognitive Functions in Later Life
Background and ObjectivesCarotid plaque reflects systemic atherosclerosis and may serve as an early marker of cognitive decline, but its longitudinal association with cognitive trajectories remains...
- 1 June 2026
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 2 (2) , e000087
Open AccessMiddle-Aged Carotid Plaque and Cognitive Functions in Later Life
Background and ObjectivesCarotid plaque reflects systemic atherosclerosis and may serve as an early marker of cognitive decline, but its longitudinal association with cognitive trajectories remains...
- Open Access
- 15 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Accelerating genetic diagnosis in the NICU: neonatologist-driven rapid whole genome sequencing
To establish a rapid whole-genome sequencing (rWGS) workflow applicable to the neonatal intensive care unit (NICU) setting and evaluate its diagnostic utility and clinical feasibility. Twenty critically ill neonates with suspected genetic disorders were included in this study. A workflow for rWGS encompassing neonate enrollment through to the return of genetic diagnosis results was established. A trio-based rWGS data analysis was performed using DRAGEN-GATK-Hail, with results reviewed and reported by a multidisciplinary team. The average turnaround time for the 20 NICU neonates was 5.5 working days. Genetic diagnoses were achieved in ten cases, resulting in a diagnostic yield of 50%, based on the clinical database and variant pathogenicity assessments. The identified diagnostic variants were located across nine genes, including AGT, ANK1, NSD1, SERPINC1, OTC (in two cases), INS, PKHD1, SAMD9, and LZTR1. The clinical implications were confirmed in all ten diagnosed neonates, with 'genetic counseling and recurrence risk management', 'early therapeutic decision-making' and 'enhancement of clinical outcomes and survival rates'. Notably, neonate rWGS-03 demonstrated the highest impact, as rWGS enabled the early identification of renal tubular dysgenesis before symptom onset. This study demonstrates the feasibility of rWGS for critically ill neonates with suspected genetic disorders admitted to the NICU. As the first implementation of neonatologist-driven rWGS in Korea, it highlights the meaningful clinical benefits of timely and accurate diagnosis. Our findings underscore its clinical value and support the integration of rWGS into routine clinical care, as well as the development of future studies within public healthcare systems.
- 15 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessAccelerating genetic diagnosis in the NICU: neonatologist-driven rapid whole genome sequencing
To establish a rapid whole-genome sequencing (rWGS) workflow applicable to the neonatal intensive care unit (NICU) setting and evaluate its diagnostic utility and clinical feasibility. Twenty critically ill neonates with suspected genetic disorders were included in this study. A workflow for rWGS encompassing neonate enrollment through to the return of genetic diagnosis results was established. A trio-based rWGS data analysis was performed using DRAGEN-GATK-Hail, with results reviewed and reported by a multidisciplinary team. The average turnaround time for the 20 NICU neonates was 5.5 working days. Genetic diagnoses were achieved in ten cases, resulting in a diagnostic yield of 50%, based on the clinical database and variant pathogenicity assessments. The identified diagnostic variants were located across nine genes, including AGT, ANK1, NSD1, SERPINC1, OTC (in two cases), INS, PKHD1, SAMD9, and LZTR1. The clinical implications were confirmed in all ten diagnosed neonates, with 'genetic counseling and recurrence risk management', 'early therapeutic decision-making' and 'enhancement of clinical outcomes and survival rates'. Notably, neonate rWGS-03 demonstrated the highest impact, as rWGS enabled the early identification of renal tubular dysgenesis before symptom onset. This study demonstrates the feasibility of rWGS for critically ill neonates with suspected genetic disorders admitted to the NICU. As the first implementation of neonatologist-driven rWGS in Korea, it highlights the meaningful clinical benefits of timely and accurate diagnosis. Our findings underscore its clinical value and support the integration of rWGS into routine clinical care, as well as the development of future studies within public healthcare systems.
- Open Access
- 1 March 2026
- Published by Korean Diabetes Association in Diabetes & Metabolism Journal
- Vol. 50 (2) , 385-395
SLC30A8 Rare Variant Modify Contribution of Common Genetic and Lifestyle Factors toward Type 2 Diabetes Mellitus
Background: This study aimed to investigate the modifying effects of rare genetic variants on the risk of type 2 diabetes mellitus (T2DM) in the context of common genetic and lifestyle factors.Methods: We conducted a comprehensive analysis of genetic and lifestyle factors associated with T2DM in a cohort of 146,284 Korean individuals. Among them, 4,603 individuals developed T2DM during the follow-up period of up to 17 years. We calculated a polygenic risk score (PRS) for T2DM and identified carriers of the rare allele I349F at SLC30A8. A Healthy Lifestyle Score (HLS) was also derived from physical activity, obesity, smoking, diet, and sodium intake levels. Using Cox proportional hazards models, we analyzed how PRS, HLS, and I349F influenced T2DM incidence.Results: Results showed that high PRS and poor lifestyle were associated with increased risk. Remarkably, I349F carriers exhibited a lower T2DM prevalence (5.7% compared to 11.7% in non-carriers) and reduced the impact of high PRS from 23.18% to 12.70%. This trend was consistent across different HLS categories, with I349F carriers displaying a lower risk of T2DM.Conclusion: The integration of common and rare genetic variants with lifestyle factors enhanced T2DM predictability in the Korean population. Our findings highlight the critical role of rare genetic variants in risk assessments and suggest that standard PRS and HLS metrics alone may be inadequate for predicting T2DM risk among carriers of such variants.
- 1 March 2026
- Published by Korean Diabetes Association in Diabetes & Metabolism Journal
- Vol. 50 (2) , 385-395
Open AccessSLC30A8 Rare Variant Modify Contribution of Common Genetic and Lifestyle Factors toward Type 2 Diabetes Mellitus
Background: This study aimed to investigate the modifying effects of rare genetic variants on the risk of type 2 diabetes mellitus (T2DM) in the context of common genetic and lifestyle factors.Methods: We conducted a comprehensive analysis of genetic and lifestyle factors associated with T2DM in a cohort of 146,284 Korean individuals. Among them, 4,603 individuals developed T2DM during the follow-up period of up to 17 years. We calculated a polygenic risk score (PRS) for T2DM and identified carriers of the rare allele I349F at SLC30A8. A Healthy Lifestyle Score (HLS) was also derived from physical activity, obesity, smoking, diet, and sodium intake levels. Using Cox proportional hazards models, we analyzed how PRS, HLS, and I349F influenced T2DM incidence.Results: Results showed that high PRS and poor lifestyle were associated with increased risk. Remarkably, I349F carriers exhibited a lower T2DM prevalence (5.7% compared to 11.7% in non-carriers) and reduced the impact of high PRS from 23.18% to 12.70%. This trend was consistent across different HLS categories, with I349F carriers displaying a lower risk of T2DM.Conclusion: The integration of common and rare genetic variants with lifestyle factors enhanced T2DM predictability in the Korean population. Our findings highlight the critical role of rare genetic variants in risk assessments and suggest that standard PRS and HLS metrics alone may be inadequate for predicting T2DM risk among carriers of such variants.
- 4 July 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (12) , 2008-2020
Development of an MHC imputation panel highlights independent contributions of HLA amino acid residues and C4 copy number variations to SLE risk
- 4 July 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (12) , 2008-2020
Development of an MHC imputation panel highlights independent contributions of HLA amino acid residues and C4 copy number variations to SLE risk
- Open Access
The SAMM50 rs3761472 causes mitochondrial dysfunction and metabolic dysfunction-associated steatotic liver disease
Genome-wide association studies (GWAS) have identified the SAMM50 rs3761472 single nucleotide polymorphism (SNP) as a risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD), although its in vivo functions remain unclear. SAMM50 encodes a mitochondrial outer membrane protein critical for maintaining mitochondrial structure. To investigate the biological effects of rs3761472, we generated Samm50 -knock-in (KI) mice harboring a D110G substitution using CRISPR/Cas9. This variant impaired mitochondrial integrity by downregulating key regulators of mitochondrial architecture, dynamics, and quality control. This contributed to reduced ATP production and elevated oxidative stress, inflammation, and hepatocyte death. The mutation also induced insulin resistance and glucose intolerance. Samm50 -KI mice fed a high-fat diet exhibited pronounced hepatic lipid accumulation and liver injury, highlighting its pathogenic role in MASLD progression. Our findings demonstrate that SAMM50 rs3761472 is a critical driver of mitochondrial dysfunction and MASLD susceptibility, supporting its potential as a therapeutic target and its relevance to precision medicine.
Open AccessThe SAMM50 rs3761472 causes mitochondrial dysfunction and metabolic dysfunction-associated steatotic liver disease
Genome-wide association studies (GWAS) have identified the SAMM50 rs3761472 single nucleotide polymorphism (SNP) as a risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD), although its in vivo functions remain unclear. SAMM50 encodes a mitochondrial outer membrane protein critical for maintaining mitochondrial structure. To investigate the biological effects of rs3761472, we generated Samm50 -knock-in (KI) mice harboring a D110G substitution using CRISPR/Cas9. This variant impaired mitochondrial integrity by downregulating key regulators of mitochondrial architecture, dynamics, and quality control. This contributed to reduced ATP production and elevated oxidative stress, inflammation, and hepatocyte death. The mutation also induced insulin resistance and glucose intolerance. Samm50 -KI mice fed a high-fat diet exhibited pronounced hepatic lipid accumulation and liver injury, highlighting its pathogenic role in MASLD progression. Our findings demonstrate that SAMM50 rs3761472 is a critical driver of mitochondrial dysfunction and MASLD susceptibility, supporting its potential as a therapeutic target and its relevance to precision medicine.